TY - JOUR KW - Adult KW - Aftercare KW - Analgesics, Opioid/adverse effects KW - Drug Overdose/drug therapy KW - Fentanyl/adverse effects KW - Hospitalization KW - Humans KW - Opioid-Related Disorders/drug therapy KW - Patient Discharge KW - Referral and Consultation KW - Drug overdose KW - Fentanyl KW - Harm Reduction KW - opioid-related disorders AU - C. A. King AU - R. Cook AU - H. Wheelock AU - P. T. Korthuis AU - J. M. Leahy AU - A. Goff AU - C. D. Morris AU - H. Englander A1 - AD - Dept. of Biomedical Engineering, School of Medicine, Oregon Health & Science University, Portland, OR, USA. Electronic address: kingca@ohsu.edu.; Dept. of Medicine, Section of Addiction Medicine, Oregon Health & Science University, Portland, OR, USA.; Outside In, Portland, OR, USA.; Dept. of Medicine, Section of Addiction Medicine, Oregon Health & Science University, Portland, OR, USA.; Oregon Health Authority, Acute and Communicable Disease Prevention, Public Health Division, Oregon Health Authority, Salem, OR, USA.; Dept. of Medicine, Section of Addiction Medicine, Oregon Health & Science University, Portland, OR, USA; Division of Hospital Medicine, Department of Medicine, Oregon Health & Science University, Portland, OR, USA.; Dept. of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University, Portland, OR, USA.; Dept. of Medicine, Section of Addiction Medicine, Oregon Health & Science University, Portland, OR, USA; Division of Hospital Medicine, Department of Medicine, Oregon Health & Science University, Portland, OR, USA. BT - The International journal on drug policy C5 - Opioids & Substance Use DO - 10.1016/j.drugpo.2021.103525 JF - The International journal on drug policy LA - eng M1 - Journal Article PB - Elsevier B.V PY - 2022 SN - 1873-4758; 0955-3959; 0955-3959 SP - 103525 T1 - Simulating the impact of Addiction Consult Services in the context of drug supply contamination, hospitalizations, and drug-related mortality T2 - The International journal on drug policy TI - Simulating the impact of Addiction Consult Services in the context of drug supply contamination, hospitalizations, and drug-related mortality U1 - Opioids & Substance Use U2 - 34837879 U3 - 10.1016/j.drugpo.2021.103525 VL - 100 VO - 1873-4758; 0955-3959; 0955-3959 Y1 - 2022 Y2 - Feb ER -